Lexology (registration) ... filed a lawsuit against Bristol-Myers Squibb Co. and Otsuka America Pharmaceutical, Inc. ("Defendants") alleging that the copayment subsidy program that Defendants offer for Abilify® ( aripiprazole )3—the Abilify Savings Card—is illegal under the ...
Victoria Times Colonist Only aripiprazole , or Abilify, is approved for use in teens 15-17 — and only for schizophrenia. “All other prescribing is off label,” Panagiotopoulos said. As of 2010-11, B.C. general practitioners were prescribing antipsychotics most often for ...
PR Newswire (press release) MONTREAL, June 6, 2013 /CNW/ - Abilify® ( aripiprazole ) has received an additional approval from Health Canada as an adjunct, or add-on, treatment to antidepressants for the treatment of major depressive disorder (MDD) in adults who had an inadequate ... and more »
PsychCentral.com (blog) In the depressed phase of bipolar disorder, only quetiapine and an olanzapine (Zyprexa)/ fluoxetine (Prozac) combination are approved as first-line treatments, although lurasidone (Latuda) is awaiting FDA approval. For mixed episodes of bipolar disorder ...
Victoria Times Colonist Only aripiprazole , or Abilify, is approved for use in teens 15-17 — and only for schizophrenia. “All other prescribing is off label,” Panagiotopoulos said. As of 2010-11, B.C. general practitioners were prescribing antipsychotics most often for ... and more »
PR Newswire (press release) MONTREAL, June 6, 2013 /CNW/ - Abilify® ( aripiprazole ) has received an additional approval from Health Canada as an adjunct, or add-on, treatment to antidepressants for the treatment of major depressive disorder (MDD) in adults who had an inadequate ... and more »
PR Newswire (press release) MONTREAL, June 6, 2013 /CNW/ - Abilify® ( aripiprazole ) has received an additional approval from Health Canada as an adjunct, or add-on, treatment to antidepressants for the treatment of major depressive disorder (MDD) in adults who had an inadequate ... and more »
LeLézard.com MONTRÉAL, le 6 juin 2013 /CNW/ - Abilify® ( aripiprazole ) a reçu une nouvelle approbation de Santé Canada et peut être administré comme traitement adjuvant...
PharmaTimes This new draft guidance focuses on the use of Abilify ( aripiprazole ) for the specific treatment of moderate to severe manic episodes in adolescents. NICE has also recommended Lithium and Lilly's blockbuster antipsychotic Zyprexa for this disorder in ... and more »
